Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -15.08
- Piotroski Score 2.00
- Grade Sector Perform
- Symbol (BLUE)
- Company bluebird bio, Inc.
- Price $0.35
- Changes Percentage (16.52%)
- Change $0.05
- Day Low $0.30
- Day High $0.36
- Year High $5.53
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's clinical study program includes HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with ß-thalassemia. It has strategic collaboration and license agreements with Orchard Therapeutics Limited, Forty Seven, Inc., and Magenta Therapeutics, Inc. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Cambridge, Massachusetts.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/25/2025
- Fiscal Year End N/A
- Average Stock Price Target $12.50
- High Stock Price Target $25.00
- Low Stock Price Target $5.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.63
- Trailing P/E Ratio -1.44
- Forward P/E Ratio -1.44
- P/E Growth -1.44
- Net Income $-211,913,000
Income Statement
Quarterly
Annual
Latest News of BLUE
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Youngstown State Penguins and the Presbyterian Blue Hose square off
Sign up for AP Top 25 Poll Alerts to receive the latest updates. Youngstown State Penguins will face Presbyterian Blue Hose in Huntsville, Texas. Youngstown State has a strong record and defensive sta...
By AP NEWS | 21 hours ago -
How winter plays important role in keeping Lake Tahoe blue
Researchers at UC Davis Tahoe Environmental Research Center conduct regular surveys to monitor the health and water clarity of Lake Tahoe. They analyze data on water quality, ecosystems, and the impac...
By CBS News | 23 hours ago -
Cary Grant's humble Bristol roots honoured with blue plaque
Hollywood legend Cary Grant's childhood home in Bristol is being recognized with a Historic England blue plaque. Grant's wife, Barbara Jaynes, shared his inspiring story of overcoming humble beginning...
By The Guardian | 23 hours ago
